Company Name: DBV Technologies S.A.

DBV Technologies S.A. is a clinical stage specialty biopharmaceutical company. The company is focused on the development and commercialization of treatments for food and pediatric allergies.  The company’s lead product candidate is a treatment for peanut allergies.

Ticker Symbol: DBVT (NASDAQ)

Company Website: www.dbv-technologies.com

Social Media:

DBV Technologies Facebook

DBV Technologies LinkedIn

DBV Technologies Twitter

Headquarters: Bagneux, France